SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-22-001840
Filing Date
2022-01-21
Accepted
2022-01-21 07:29:33
Documents
3
Period of Report
2022-01-21

Document Format Files

Seq Description Document Type Size
1 6-K asln-6k_20220121.htm 6-K 25631
2 EX-99.1 asln-ex991_6.htm EX-99.1 86577
3 GRAPHIC gksfqeocedz2000001.jpg GRAPHIC 9744
  Complete submission text file 0001564590-22-001840.txt   126822
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38475 | Film No.: 22544132
SIC: 2834 Pharmaceutical Preparations